29 November 2018

Jeroen van der Laak and Francesco Ciompi have been awarded an ICT12 H2020 grant of € 4.3M with € 675K for Radboudumc as part of a consortium of partners.

Exa-scale volumes of diverse data from distributed sources are continuously produced. Healthcare data stand out because of size, heterogeneity, the information present in the data and its potential commercial value. Healthcare data produced in 2013 were 153 exabytes, while the data produced in 2020 will be over 2’000 exabytes, posing a challenge for clinicians who need to examine these volumes. Healthcare data are highly heterogeneous, since they include various types of images and signals, time series and medical reports. Text is a unique resource because medical reports carefully describe the diagnosis associated to multimodal and multimedia data. Moreover, text is also used in scientific papers and blog posts to describe specific images, thus making healthcare related data potentially the biggest annotated data collection worldwide.
EXA MODE’s overall aim is to allow easy and fast, weakly supervised knowledge discovery of exa-scale heterogeneous data in the field of digital pathology. Knowledge extracted from data will be used to build computer algorithms based on artificial intelligence, to assist pathologists in routine diagnostics.

EXA MODE is a consortium consisting of academic research groups and companies from several European countries: Netherlands, Switzerland, Italy, Bulgaria, Poland. Together with Radboudumc, the national supercomputing center SURFSara is part of this consortium. ICT12 is an EU program in the Horizon 2020 framework for financing projects on “Big Data technologies and extreme-scale analytics”.

Jeroen van der Laak is member of theme Women's cancers.
Francesco Ciompi is member of theme Tumors of the digestive tract.

Related news items


Awarded KWF grants for Radboudumc researchers

18 December 2019 KWF is investing 2.7 million euros in five different studies at Radboudumc. The awards are part of the new round of funding by DCS, in which over 34 million euros will be granted to Dutch cancer research. We congratulate our researchers with this funding and wish them success with their great work. read more

Exploration meeting Academic Alliance on Oncology

2 December 2019 Within the Academic Alliance, the Maastricht UMC+ and Radboudumc are already working together in several areas. And this is happening in more and more fields. On 27 November researchers from both umc's met during the fourth Exploration meeting, this time with the theme: Oncology. read more

KWF Roadshow 11 November 2019

10 October 2019 In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field. read more

Bart Kiemeney finishes 1st in the Tour and raises thousands of euros

30 July 2019 With over €47,000 on the counter, Kiemeney can see the Tour de France as a great success. read more

Internal KWF review procedure 2020

13 June 2019 In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications. read more

Universal tumor BRCA1/2 testing of ovarian cancer

13 May 2019 Marjolijn Ligtenberg, Janet Vos and Nicoline Hoogerbrugge, assessed the feasibility of a workflow for universal tumor DNA BRCA1/2 testing of all newly diagnosed OC patients as prescreen for PARPi treatment and cancer predisposition testing. They have published their findings in the JNCI. read more